GSK Investigation Concludes The MHRA has concluded its four year investigation into Glaxosmithkline and its antidepressant drug Seroxat. The investigation focused on whether GSK had failed to inform the MHRA of information it had on the safety of Seroxat in under 18's in a timely manner. The investigation was undertaken with a view to a potential criminal prosecution for breach of drug safety legislation.
Source: www.medicalnewstoday.comPMT Drug? Not Yet "Discovery raises hopes of drug for PMT," is the headline in The Daily Telegraph . The newspaper article reports that scientists studying the condition have "isolated a protein linked to the condition, raising hopes that a drug could be developed to block its effects". The research "may also have benefits for epilepsy sufferers", the newspaper says.
Source: www.medicalnewstoday.comEMEA Reports Strong Performance In Regulatory And Public-Health Activities In 2007 Application numbers for initial marketing authorisations, post-authorisation variations and requests for scientific advice relating to
medicines for human use were all higher in 2007 than in any previous year, according to the EMEA annual report 2007 adopted by the Agency's Management Board on 6 March 2008. A greater number of positive opinions were adopted too, contributing to the increased availability of new and innovative
medicines for patients in Europe.
Source: www.medicalnewstoday.com
# posted by Network @ 6:00 PM
